Skip to content

Clinical trials

Observational Carcinoma, Transitional Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Phase: Observational Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20091
20102
20113
20122
20131
20141
20151
20165
20175
20184
201910
20208
20218
20229
202310
202410
202511
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting31
Completed31
Unknown status25
Not yet recruiting6
Terminated6
Active, not recruiting4
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Changhai Hospital6
National Taiwan University Hospital5
Hoffmann-La Roche4
Assiut University3
British Urology Researchers in Surgical Training3
Pacific Edge Limited3
Pfizer3
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
AstraZeneca2
China Medical University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell105
Urinary Bladder Neoplasms36
Carcinoma, Renal Cell11
Hematuria10
Carcinoma, Hepatocellular7
Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Head and Neck Neoplasms6
Kidney Neoplasms6
Melanoma5

Trials

Showing 26 to 50 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.